Application | Comment | Organism |
---|---|---|
drug development | fucosyltransferase VII is a very promising drug target for treatment of inflammatory skin diseases | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression of FucTVII catalytic domain in HEK-293 cells | Homo sapiens |
General Stability | Organism |
---|---|
FucTVII is very stable against freeze/thaw cycles | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
6-F-GDP-fucose | complete inhibition | Homo sapiens | |
GDP-fucose | competitive inhibition | Homo sapiens | |
additional information | high-throughput screening for FucTVII inhibitors, overview | Homo sapiens | |
Neu5(OHAc)alpha(2-3)Galbeta(1-4)GlcNAc-beta-(3-amino)propyl | - |
Homo sapiens | |
Neu5Acalpha(2-3)Galbeta(1-4)6-deoxyGlcNAc-beta-methyl | - |
Homo sapiens | |
Neu5Acalpha(2-3)Galbeta(1-4)6-sulfoGlcNAc-beta-methyl | - |
Homo sapiens | |
Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta(1-3)LacN-(2-acetamido)ethyl | - |
Homo sapiens | |
Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta(1-6)GalNAc-(2-acetamido)ethyl | - |
Homo sapiens | |
Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta-(3-amino)propyl | - |
Homo sapiens | |
Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta-biphenyl-4-carboxylic acid propyl amide | - |
Homo sapiens | |
Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta-methyl | - |
Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00012 | - |
GDP-beta-L-fucose | pH 7.4, 22°C | Homo sapiens | |
0.05 | - |
Neu5Acalpha(2,3)-Galbeta(1,4)-6-O-sulfo-GlcNAc beta-O-C3H6-biotin | pH 7.4, 22°C | Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mn2+ | preferred divalent cation | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
GDP-beta-L-fucose + Neu5Acalpha-(2,3)-Galbeta-(1,4)-GlcNAcbeta-R | Homo sapiens | the last step in sLex epitope formation is catalyzed byalpha(1,3)-fucosyltransferase VII, i.e. FucTVII, which transfers a fucosyl moiety from GDP-fucose to the core oligosaccharide structures, overview | GDP + Neu5Acalpha-(2,3)-Galbeta-(1,4)-[Fucalpha-(1,3)]-GlcNAcbeta-R | i.e. antigen sLex | ? | |
additional information | Homo sapiens | the natural substrate of FucTVII is a glycoprotein carrying 3'SLN-terminated polylactoseamine chains, FucTVII activity is required for synthesis of the sialyl-Lewis X glycoepitopes on the E- and P-selectin ligands, necessary for lymphocyte migration into the skin | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
GDP-beta-L-fucose + fetuin | - |
Homo sapiens | ? | - |
? | |
GDP-beta-L-fucose + fetuin-biotin | - |
Homo sapiens | ? | - |
? | |
GDP-beta-L-fucose + Neu5Ac alpha(2,3)-Galbeta(1,4)-6-O-sulfo-GlcNAc beta-O-C3H6-biotin | i.e. 6-sulfo-3'SLN, best substrate | Homo sapiens | ? | - |
? | |
GDP-beta-L-fucose + Neu5Ac alpha(2,3)-Galbeta(1,4)-GlcNAc beta-(1,3)-Galbeta-(1,4)-Glcbeta-O-C3H6-biotin | i.e. 3'SLNL | Homo sapiens | ? | - |
? | |
GDP-beta-L-fucose + Neu5Ac alpha(2,3)-Galbeta(1,4)-GlcNAc beta-O-BSA-biotin | i.e. 3'SLN-BSA | Homo sapiens | ? | - |
? | |
GDP-beta-L-fucose + Neu5Ac alpha(2,3)-Galbeta(1,4)-GlcNAc beta-O-C3H6-biotin | i.e. 3'SLN | Homo sapiens | ? | - |
? | |
GDP-beta-L-fucose + Neu5Acalpha-(2,3)-Galbeta-(1,4)-GlcNAcbeta-R | the last step in sLex epitope formation is catalyzed byalpha(1,3)-fucosyltransferase VII, i.e. FucTVII, which transfers a fucosyl moiety from GDP-fucose to the core oligosaccharide structures, overview | Homo sapiens | GDP + Neu5Acalpha-(2,3)-Galbeta-(1,4)-[Fucalpha-(1,3)]-GlcNAcbeta-R | i.e. antigen sLex | ? | |
additional information | the natural substrate of FucTVII is a glycoprotein carrying 3'SLN-terminated polylactoseamine chains, FucTVII activity is required for synthesis of the sialyl-Lewis X glycoepitopes on the E- and P-selectin ligands, necessary for lymphocyte migration into the skin | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
alpha(1,3)-fucosyltransferase VII | - |
Homo sapiens |
FucTVII | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
22 | - |
assay at room temperature | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0002 | - |
6-F-GDP-fucose | pH 7.4, 22°C | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00064 | - |
pH 7.4, 22°C | Homo sapiens | 6-F-GDP-fucose | |
0.0104 | - |
pH 7.4, 22°C | Homo sapiens | Neu5Acalpha(2-3)Galbeta(1-4)6-sulfoGlcNAc-beta-methyl | |
0.0143 | - |
pH 7.4, 22°C | Homo sapiens | Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta-biphenyl-4-carboxylic acid propyl amide | |
0.0279 | - |
pH 7.4, 22°C | Homo sapiens | Neu5Acalpha(2-3)Galbeta(1-4)6-deoxyGlcNAc-beta-methyl | |
0.0347 | - |
pH 7.4, 22°C | Homo sapiens | Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta(1-6)GalNAc-(2-acetamido)ethyl | |
0.035 | - |
pH 7.4, 22°C | Homo sapiens | Neu5(OHAc)alpha(2-3)Galbeta(1-4)GlcNAc-beta-(3-amino)propyl | |
0.0516 | - |
pH 7.4, 22°C | Homo sapiens | Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta-methyl | |
0.0838 | - |
pH 7.4, 22°C | Homo sapiens | Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta(1-3)LacN-(2-acetamido)ethyl | |
0.227 | - |
pH 7.4, 22°C | Homo sapiens | Neu5Acalpha(2-3)Galbeta(1-4)GlcNAc-beta-(3-amino)propyl |